GlobalFoundries picks Redpanda for real-time data platform
Get Alerts GFS Hot Sheet
Overall Analyst Rating:
SELL (= Flat)
Dividend Yield: 0.6%
Revenue Growth %: +11.8%
Join SI Premium – FREE
GlobalFoundries (NASDAQ: GFS) has selected Redpanda as a technology partner to build a unified real-time data platform across its semiconductor manufacturing operations, according to a press release from Redpanda.
The Redpanda Data Platform replaces GlobalFoundries' legacy change-data-capture infrastructure to stream equipment, process, and scientific data from its manufacturing operations. The platform connects manufacturing, engineering, and business systems across GlobalFoundries' global sites in the U.S., Europe, and Asia.
Redpanda's forward-deployed engineers are working alongside GlobalFoundries teams to modernize digital manufacturing capabilities. Tier-0, mission-critical systems are already live in production, the companies said.
GlobalFoundries is also using Redpanda's Agentic Data Plane to build a portfolio of AI agents targeting automation and operational efficiency across IT, procurement, and other business functions. The company said it plans to expand adoption over time.
"Semiconductor manufacturing depends on trusted, real-time access to operational data and, at GF, we are continually investing in the digital capabilities needed to support increasingly complex manufacturing operations," said Vishal Mehra, SVP and Chief Information Officer at GlobalFoundries. "Working with Redpanda, we are building a modern, scalable data infrastructure that improves operational visibility and accelerates decision-making at global scale."
Alex Gallego, founder and CEO of Redpanda, said the platform is designed to apply the governance, confidentiality, and access controls required in semiconductor manufacturing to environments where AI agents are also consuming data in real time.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- ADARx Pharmaceuticals files for proposed IPO
- CORVEX (MOVE) files $500M mixed shelf
- Novartis pelacarsen trial fails to meet primary endpoint
Create E-mail Alert Related Categories
Corporate NewsRelated Entities
Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share